B‐type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis

BACKGROUND: We aimed to assess longitudinal changes of B‐type natriuretic peptide (BNP) in aortic stenosis (AS) patients treated by transcatheter aortic valve replacement (TAVR). METHODS: From our TAVR database, we identified 193 consecutive patients with severe symptomatic AS who underwent TAVR and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Kimi, Kumar, Arnav, Krishnaswamy, Amar, Mick, Stephanie, Desai, Milind Y., Griffin, Brian P., Kapadia, Samir R., Popović, Zoran B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2018
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712326/
https://www.ncbi.nlm.nih.gov/pubmed/30565264
http://dx.doi.org/10.1002/clc.23138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712326/
https://www.ncbi.nlm.nih.gov/pubmed/30565264
http://dx.doi.org/10.1002/clc.23138

Ejemplares similares